Guggenheim Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
35,542
+7,536
| +27% | +$245K | 0.01% | 831 |
|
|
2025
Q1 | $1.06M | Buy |
28,006
+1,556
| +6% | +$58.8K | 0.01% | 857 |
|
|
2024
Q4 | $2.17M | Sell |
26,450
-3,350
| -11% | -$274K | 0.02% | 623 |
|
|
2024
Q3 | $3.41M | Sell |
29,800
-224
| -0.7% | -$25.6K | 0.02% | 648 |
|
|
2024
Q2 | $2.27M | Sell |
30,024
-1,448
| -5% | -$109K | 0.02% | 770 |
|
|
2024
Q1 | $2.15M | Buy |
31,472
+3,915
| +14% | +$267K | 0.02% | 855 |
|
|
2023
Q4 | $1.73M | Sell |
27,557
-2,729
| -9% | -$171K | 0.01% | 901 |
|
|
2023
Q3 | $1.54M | Buy |
30,286
+1,225
| +4% | +$62.5K | 0.01% | 907 |
|
|
2023
Q2 | $1.45M | Buy |
29,061
+4,672
| +19% | +$233K | 0.01% | 990 |
|
|
2023
Q1 | $914K | Buy |
+24,389
| New | +$914K | 0.01% | 1225 |
|